Pay in 4 interest-free payments of $5.29 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Can you find independent test reports or reviews confirming stated quality
Impurities can introduce confounding variables, compromising the integrity of your research data
Practical considerations such as injection frequency, needle size, and gastrointestinal tolerability may also influence individual patient selection
Currently undergoing Phase 2 trials, bimagrumab was originally developed by Novartis, but the drug has switched hands to Versanis, which was subsequently acquired by Eli Lilly
US$ 23.08
US$ 24.23
US$ 27.36
US$ 26.19
